1. Compliance issues in manufacturing of drugs;Kaufman;Ocul Surf,2003
2. Chen M-L, Patnaik R. Guidance on statistical procedures for bioequivalence studies using a standard two-treatment crossover design. Rockville MD: The Division of Bioequivalence, Office of Generic Drugs. US Food and Drug Administration, 1992
3. Types of bioequivalence and related statistical considerations;Hauck;Int J Clin Pharmacol Ther Toxicol,1992
4. A 12-month, multicenter, randomized, double-masked, parallel-group comparison of Timolol-LA once daily and timolol maleate solution twice daily in the treatment of adults with ocular hypertension or open-angle glaucoma;Mundorf;Clin Ther,2004